Absci (ABSI) Total Non-Current Liabilities (2020 - 2026)

Absci (ABSI) reported Total Non-Current Liabilities of $22.8 million for Q1 2026, down 28.62% on a YoY basis from $32.0 million in Q1 2025, and down 11.65% sequentially from $25.8 million in Q4 2025.

Absci (ABSI) Total Non-Current Liabilities (2020 - 2026) Analysis & Trends

Absci (ABSI) has 7 years of Total Non-Current Liabilities data on file, last reported at $22.8 million in Q1 2026.

  • For the quarter ending Q1 2026, Total Non-Current Liabilities fell 28.62% year-over-year to $22.8 million; the trailing twelve-month figure through Mar 2026 stood at $22.8 million (down 28.62% YoY), and the FY2025 full-year result was $25.8 million, down 24.8% from the prior year.
  • Total Non-Current Liabilities slipped to $22.8 million in Q1 2026, from $25.8 million in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $54.7 million in Q1 2022 to a low of $22.8 million in Q1 2026.
  • A 5-year average of $37.9 million and a median of $35.0 million in 2025 frame the typical range for Total Non-Current Liabilities.
  • Across the five-year window, Total Non-Current Liabilities tumbled 75.66% in 2022 and climbed 2.97% in 2025, its largest moves.
  • Tracing ABSI's Total Non-Current Liabilities over 5 years: stood at $46.6 million in 2022, then retreated by 12.31% to $40.8 million in 2023, then slipped by 15.88% to $34.3 million in 2024, then declined by 24.8% to $25.8 million in 2025, then declined by 11.65% to $22.8 million in 2026.
  • Business Quant data shows ABSI's Total Non-Current Liabilities at $22.8 million in Q1 2026, $25.8 million in Q4 2025, and $32.9 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 4.45 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 110.28 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1.98 Bn
4 NuCana 279.75 Bn 279.75 Bn - 949,738.67
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 5.87 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 7.32 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 40.00 Mn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 746.94 Mn
10 Absci 1.23 Bn 1.11 Bn - 22.82 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 22.82 Mn
Dec 31, 2025 25.83 Mn
Sep 30, 2025 32.87 Mn
Jun 30, 2025 35.04 Mn
Mar 31, 2025 31.97 Mn
Dec 31, 2024 34.34 Mn
Sep 30, 2024 33.87 Mn
Jun 30, 2024 34.03 Mn
Mar 31, 2024 34.71 Mn
Dec 31, 2023 40.83 Mn
Sep 30, 2023 39.93 Mn
Jun 30, 2023 38.75 Mn
Mar 31, 2023 41.84 Mn
Dec 31, 2022 46.56 Mn
Sep 30, 2022 46.41 Mn
Jun 30, 2022 49.90 Mn
Mar 31, 2022 54.74 Mn
Dec 31, 2021 47.93 Mn
Sep 30, 2021 48.98 Mn
Jun 30, 2021 204.96 Mn